Clinical Trial: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499232) titled 'A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease' on March 23.

Brief Summary: The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

Study Start Date: April 20

Study Type: INTERVENTIONAL

Condition: Crohn Disease

Intervention: DRUG: Guselkumab

Guselkumab will be administered.

DRUG: Risankizumab

Risankizumab will be administered.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ja...